{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:29:53Z","timestamp":1790645393512,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"ministero dell\u2019istruzione, dell\u2019universit\u00e0 e della ricerca","doi-asserted-by":"publisher","award":["PON-AIM line 1- Id. AIM1892002"],"award-info":[{"award-number":["PON-AIM line 1- Id. AIM1892002"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose\n<\/jats:title>\n                <jats:p>The prevention and early diagnosis of medication-related osteonecrosis of the jaw (MRONJ) is fundamental to reducing the incidence and progression of MRONJ. Many in the field believe that dental hygienists should play an integral role in primary and secondary MRONJ prevention. However, to date, very few publications in the literature have proposed standardised MRONJ protocols, which are dedicated to dental hygienists. The aim of this study was to provide guidance to the health care providers managing MRONJ.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expert opinion in this study was developed by dental hygienists from the main Italian technical-scientific associations (Italian Dental Hygienists Association, AIDI and National Union of Dental Hygienists, UNID) and authors of the latest Italian recommendations regarding MRONJ from the field of dentistry and maxillofacial surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The oral care protocol outlined in this position paper is focused on the role of dental hygienist in patients at risk or affected by MRONJ, and it regards 3 main issues: primary prevention, secondary prevention and supporting the treatment of MRONJ. Each issue contains easy-to-apply indications and procedures, as described by the authors, regarding the role of the dental hygienist.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Referring to the main issues under consideration (primary prevention, secondary prevention and the treatment of MRONJ), a clinical examination of periodontal tissue is critical in preventing MRONJ. It is the opinion of the authors of this study that the application of a periodontal screening score is fundamental in defining personalised strategies for patients at risk of MRONJ. By means of these basic procedures, a protocol for assisting the health care provider and the presentation of a practical approach for patients at risk or affected by MRONJ are described in this study.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-022-06940-8","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T04:43:35Z","timestamp":1647405815000},"page":"6429-6440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4008-6502","authenticated-orcid":false,"given":"Rodolfo","family":"Mauceri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4956-8556","authenticated-orcid":false,"given":"Rita","family":"Coniglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-0941","authenticated-orcid":false,"given":"Antonia","family":"Abbinante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5501-8051","authenticated-orcid":false,"given":"Paola","family":"Carcieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5451-0602","authenticated-orcid":false,"given":"Domenico","family":"Tomassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-6020","authenticated-orcid":false,"given":"Vera","family":"Panzarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-7420","authenticated-orcid":false,"given":"Olga","family":"Di Fede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-7340","authenticated-orcid":false,"given":"Francesco","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-9820","authenticated-orcid":false,"given":"Vittorio","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-4508","authenticated-orcid":false,"given":"Alberto","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9443-0495","authenticated-orcid":false,"given":"Giuseppina","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"6940_CR1","doi-asserted-by":"publisher","DOI":"10.32388\/594095","volume-title":"Medication related osteonecrosis of the jaw (MRONJ)","author":"A Bedogni","year":"2018","unstructured":"Bedogni A, Campisi G, Fusco V (2018) Medication related osteonecrosis of the jaw (MRONJ). Qeios, London"},{"key":"6940_CR2","volume-title":"Raccomandazioni clinico-terapeutiche sull\u2019osteonecrosi delle ossa mascellari (ONJ) farmaco-relata e sua prevenzione","author":"G Campisi","year":"2020","unstructured":"Campisi G, Bedogni A, Fusco V (2020) Raccomandazioni clinico-terapeutiche sull\u2019osteonecrosi delle ossa mascellari (ONJ) farmaco-relata e sua prevenzione. Palermo University Press, Palermo"},{"key":"6940_CR3","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/odi.13160","volume":"25","author":"M Schiodt","year":"2019","unstructured":"Schiodt M, Otto S, Fedele S et al (2019) Workshop of European task force on medication-related osteonecrosis of the jaw\u2014current challenges. Oral Dis 25:1815\u20131821. https:\/\/doi.org\/10.1111\/odi.13160","journal-title":"Oral Dis"},{"key":"6940_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2217\/fon.13.211","volume":"10","author":"G Campisi","year":"2014","unstructured":"Campisi G, Fedele S, Fusco V et al (2014) Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents. Future Oncol 10:257\u2013275. https:\/\/doi.org\/10.2217\/fon.13.211","journal-title":"Future Oncol"},{"key":"6940_CR5","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"6940_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00520-018-4501-x","volume":"27","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Kouri M, Papadopoulou E et al (2019) Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Support Care Cancer 27:383\u2013394. https:\/\/doi.org\/10.1007\/s00520-018-4501-x","journal-title":"Support Care Cancer"},{"key":"6940_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/odi.12447","volume":"22","author":"J Bagan","year":"2016","unstructured":"Bagan J, Peydr\u00f3 A, Calvo J et al (2016) Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis. Oral Dis 22:324\u2013329. https:\/\/doi.org\/10.1111\/odi.12447","journal-title":"Oral Dis"},{"key":"6940_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/14740338.2016.1177021","volume":"15","author":"V Fusco","year":"2016","unstructured":"Fusco V, Santini D, Armento G et al (2016) Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology. Expert Opin Drug Saf 15:925\u2013935. https:\/\/doi.org\/10.1080\/14740338.2016.1177021","journal-title":"Expert Opin Drug Saf"},{"key":"6940_CR9","first-page":"c85","volume":"78","author":"M Troeltzsch","year":"2012","unstructured":"Troeltzsch M, Woodlock T, Kriegelstein S et al (2012) Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw. J Can Dent Assoc 78:c85","journal-title":"J Can Dent Assoc"},{"key":"6940_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/odi.12632","volume":"23","author":"P Fung","year":"2017","unstructured":"Fung P, Bedogni G, Bedogni A et al (2017) Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study. Oral Dis 23:477\u2013483. https:\/\/doi.org\/10.1111\/odi.12632","journal-title":"Oral Dis"},{"key":"6940_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","volume":"127","author":"O Nicolatou-Galitis","year":"2019","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes RA et al (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 127:117\u2013135. https:\/\/doi.org\/10.1016\/j.oooo.2018.09.008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"6940_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SCS.0000000000004087","volume":"00","author":"G Oteri","year":"2017","unstructured":"Oteri G, De Ponte FS, Runci M et al (2017) Oral-health-related quality of life after surgical treatment of osteonecrosis of the jaws. J Craniofac Surg 00:1. https:\/\/doi.org\/10.1097\/SCS.0000000000004087","journal-title":"J Craniofac Surg"},{"key":"6940_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C et al (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20:117\u2013120. https:\/\/doi.org\/10.1093\/annonc\/mdn554","journal-title":"Ann Oncol"},{"key":"6940_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/annonc\/mdr039","volume":"23","author":"AM Vandone","year":"2012","unstructured":"Vandone AM, Donadio M, Mozzati M et al (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol 23:193\u2013200. https:\/\/doi.org\/10.1093\/annonc\/mdr039","journal-title":"Ann Oncol"},{"key":"6940_CR15","first-page":"b147","volume":"77","author":"R Bonacina","year":"2011","unstructured":"Bonacina R, Mariani U, Villa F, Villa A (2011) Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc 77:b147","journal-title":"J Can Dent Assoc"},{"key":"6940_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T et al (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20:137\u2013145. https:\/\/doi.org\/10.1093\/annonc\/mdn526","journal-title":"Ann Oncol"},{"key":"6940_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","volume":"125","author":"AA Owosho","year":"2018","unstructured":"Owosho AA, Liang STY, Sax AZ et al (2018) Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Oral Surg Oral Med Oral Pathol Oral Radiol 125:440\u2013445. https:\/\/doi.org\/10.1016\/j.oooo.2018.02.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"6940_CR18","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00520-020-05440-x","volume":"28","author":"L Drudge-Coates","year":"2020","unstructured":"Drudge-Coates L, Van den Wyngaert T, Schi\u00f8dt M et al (2020) Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals. Support Care Cancer 28:4019\u20134029. https:\/\/doi.org\/10.1007\/s00520-020-05440-x","journal-title":"Support Care Cancer"},{"key":"6940_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/idh.12122","volume":"13","author":"YJ Mah","year":"2015","unstructured":"Mah YJ, Kang GY, Kim SJ (2015) Survey on awareness and perceptions of bisphosphonate-related osteonecrosis of the jaw in dental hygienists in Seoul. Int J Dent Hyg 13:222\u2013227. https:\/\/doi.org\/10.1111\/idh.12122","journal-title":"Int J Dent Hyg"},{"key":"6940_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1601-5037.2009.00409.x","volume":"8","author":"A Kyrgidis","year":"2010","unstructured":"Kyrgidis A, Teleioudis Z, Vahtsevanos K (2010) The role of dental hygienist in the prevention of osteonecrosis of the jaw in patients wearing dentures. Int J Dent Hyg 8:154","journal-title":"Int J Dent Hyg"},{"key":"6940_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1601-5037.2008.00331.x","volume":"7","author":"S Rayman","year":"2009","unstructured":"Rayman S, Almas K, Dincer E (2009) Bisphosphonate-related jaw necrosis: a team approach management and prevention. Int J Dent Hyg 7:90\u201395. https:\/\/doi.org\/10.1111\/j.1601-5037.2008.00331.x","journal-title":"Int J Dent Hyg"},{"key":"6940_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/J.1601-5037.2008.00342.X","volume":"6","author":"S Barrow","year":"2008","unstructured":"Barrow S, yan L, (2008) Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw. Int J Dent Hyg 6:376\u2013377. https:\/\/doi.org\/10.1111\/J.1601-5037.2008.00342.X","journal-title":"Int J Dent Hyg"},{"key":"6940_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.jcms.2020.02.017","volume":"48","author":"J Vanpoecke","year":"2020","unstructured":"Vanpoecke J, Verstraete L, Smeets M et al (2020) Medication-related osteonecrosis of the jaw (MRONJ) stage III: conservative and conservative surgical approaches versus an aggressive surgical intervention: a systematic review. J Craniomaxillofac Surg 48:435\u2013443. https:\/\/doi.org\/10.1016\/j.jcms.2020.02.017","journal-title":"J Craniomaxillofac Surg"},{"key":"6940_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41413-020-0088-1","volume":"8","author":"JT Wan","year":"2020","unstructured":"Wan JT, Sheeley DM, Somerman MJ, Lee JS (2020) Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res 8:14. https:\/\/doi.org\/10.1038\/s41413-020-0088-1","journal-title":"Bone Res"},{"key":"6940_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17165998","volume":"17","author":"G Campisi","year":"2020","unstructured":"Campisi G, Mauceri R, Bertoldo F et al (2020) Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. Int J Environ Res Public Health 17:1\u201315. https:\/\/doi.org\/10.3390\/ijerph17165998","journal-title":"Int J Environ Res Public Health"},{"key":"6940_CR26","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/odi.13294","volume":"26","author":"O Nicolatou-Galitis","year":"2020","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Vardas E et al (2020) Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents. Oral Dis 26:955\u2013966. https:\/\/doi.org\/10.1111\/odi.13294","journal-title":"Oral Dis"},{"key":"6940_CR27","doi-asserted-by":"publisher","unstructured":"Woolley J, Akintola O, Yates J, et al (2021) The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: a systematic review. Heliyon 7:. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e05914","DOI":"10.1016\/j.heliyon.2021.e05914"},{"key":"6940_CR28","doi-asserted-by":"publisher","unstructured":"Escobedo MF, Junquera S, Gonzalez C, Vasatyuk S, Gallego L, Barbeito E, Junquera LM (2022) Efficacy of complementary treatment with autologous platelet concentrates and\/or mesenchymal stem cells in chemical osteonecrosis of the jaw. Systematic review of the literature. J Stomatol Oral Maxillofac Surg 123(1):51\u201358. https:\/\/doi.org\/10.1016\/j.jormas.2021.01.015","DOI":"10.1016\/j.jormas.2021.01.015"},{"key":"6940_CR29","doi-asserted-by":"publisher","first-page":"606043","DOI":"10.3389\/fimmu.2021.606043","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Gao L, Ren W et al (2021) The role of the immune response in the development of medication-related osteonecrosis of the jaw. Front Immunol 12:606043. https:\/\/doi.org\/10.3389\/fimmu.2021.606043","journal-title":"Front Immunol"},{"key":"6940_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/medicina57050463","volume":"57","author":"S Otto","year":"2021","unstructured":"Otto S, Aljohani S, Fliefel R et al (2021) Infection as an important factor in medication-related osteonecrosis of the jaw (MRONJ). Med 57:463. https:\/\/doi.org\/10.3390\/medicina57050463","journal-title":"Med"},{"key":"6940_CR31","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00784-020-03423-0","volume":"24","author":"C Moreno-Rabi\u00e9","year":"2020","unstructured":"Moreno-Rabi\u00e9 C, Ga\u00eata-Araujo H, Oliveira-Santos C et al (2020) Early imaging signs of the use of antiresorptive medication and MRONJ: a systematic review. Clin Oral Investig 24:2973\u20132989. https:\/\/doi.org\/10.1007\/s00784-020-03423-0","journal-title":"Clin Oral Investig"},{"key":"6940_CR32","doi-asserted-by":"publisher","first-page":"4021952","DOI":"10.1155\/2018\/4021952","volume":"2018","author":"G Oteri","year":"2018","unstructured":"Oteri G, Campisi G, Panzarella V et al (2018) Could the combined administration of bone antiresorptive drug, taxanes, and corticosteroids worsen medication related osteonecrosis of the jaws in cancer patients? Biomed Res Int 2018:4021952. https:\/\/doi.org\/10.1155\/2018\/4021952","journal-title":"Biomed Res Int"},{"key":"6940_CR33","first-page":"341","volume":"50","author":"Y Zadik","year":"2019","unstructured":"Zadik Y (2019) The unexpected role of dental practitioners in the prevention of hip fractures and related deaths. Quintessence Int (Berl) 50:341\u2013342","journal-title":"Quintessence Int (Berl)"},{"key":"6940_CR34","unstructured":"Ministero Della Salute (2014) Raccomandazioni per la promozione della salute orale, la prevenzione delle patologie orali e la terapia odontostomatologica nei pazienti adulti con malattia neoplastica - Available online: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2139_allegato.pdf. Accessed 31 Aug 2021"},{"key":"6940_CR35","doi-asserted-by":"publisher","unstructured":"James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A, Whelton H, Riley P (2017) Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev 3(3):CD008676. https:\/\/doi.org\/10.1002\/14651858.CD008676.pub2","DOI":"10.1002\/14651858.CD008676.pub2"},{"key":"6940_CR36","unstructured":"Esther M. Wilkins (2017) La Pratica Clinica dell\u2019Igienista Orale. Publisher: Piccin"},{"key":"6940_CR37","unstructured":"Cairo F, Carrassi A, De Paoli S, Roccuzzo M, Trombelli L (2020) La diagnosi in Parodontologia, SIDP. Available online https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiQl7X95Lv2AhUDjqQKHbC7CBgQFnoECAIQAQ&url=https%3A%2F%2Fimedica.it%2Fwpcontent%2Fuploads%2F2020%2F07%2FLA-DIAGNOSI-IN-PARODONTOLOGIA-.pdf&usg=AOvVaw1_H8iAm8bR0DqtswlHmBe6. Accessed 31 Aug 2021"},{"key":"6940_CR38","doi-asserted-by":"publisher","first-page":"103497","DOI":"10.1016\/j.jdent.2020.103497","volume":"103","author":"ZLS Brookes","year":"2020","unstructured":"Brookes ZLS, Bescos R, Belfield LA et al (2020) Current uses of chlorhexidine for management of oral disease: a narrative review. J Dent 103:103497","journal-title":"J Dent"},{"key":"6940_CR39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1532-849X.2010.00683.x","volume":"20","author":"D Felton","year":"2011","unstructured":"Felton D, Cooper L, Duqum I et al (2011) Evidence-based guidelines for the care and maintenance of complete dentures: a publication of the American College of Prosthodontists. J Prosthodont 20:S1\u2013S12. https:\/\/doi.org\/10.1111\/j.1532-849X.2010.00683.x","journal-title":"J Prosthodont"},{"key":"6940_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/0022034514560768","volume":"94","author":"A Peer","year":"2015","unstructured":"Peer A, Khamaisi M (2015) Diabetes as a risk factor for medication-related osteonecrosis of the jaw. J Dent Res 94:252\u2013260. https:\/\/doi.org\/10.1177\/0022034514560768","journal-title":"J Dent Res"},{"key":"6940_CR41","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1210\/jc.2013-2434","volume":"98","author":"S Molcho","year":"2013","unstructured":"Molcho S, Peer A, Berg T et al (2013) Diabetes microvascular disease and the risk for bisphosphonate-related osteonecrosis of the jaw: a single center study. J Clin Endocrinol Metab 98:1807\u20131812. https:\/\/doi.org\/10.1210\/jc.2013-2434","journal-title":"J Clin Endocrinol Metab"},{"key":"6940_CR42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5125\/jkaoms.2016.42.5.271","volume":"42","author":"SJ Paek","year":"2016","unstructured":"Paek SJ, Park W-J, Shin H-S et al (2016) Diseases having an influence on inhibition of angiogenesis as risk factors of osteonecrosis of the jaw. J Korean Assoc Oral Maxillofac Surg 42:271\u2013277. https:\/\/doi.org\/10.5125\/jkaoms.2016.42.5.271","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"6940_CR43","doi-asserted-by":"crossref","unstructured":"Valenzuela L, Alonso-Bouz\u00f5n C, Ma\u00f1as LR et al (2015) Bisphosphonate-related osteonecrosis of the jaw in an 80-year-old woman with diabetes mellitus: case report. Blackwell Publishing Inc","DOI":"10.1111\/jgs.13689"},{"key":"6940_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/154405910508400301","volume":"84","author":"R Proctor","year":"2005","unstructured":"Proctor R, Kumar N, Stein A et al (2005) Oral and dental aspects of chronic renal failure. J Dent Res 84:199\u2013208","journal-title":"J Dent Res"},{"key":"6940_CR45","first-page":"369","volume":"21","author":"PL Foglio-Bonda","year":"2017","unstructured":"Foglio-Bonda PL, Brilli K, Pattarino F, Foglio-Bonda A (2017) Salivary flow rate and pH in patients with oral pathologies. Eur Rev Med Pharmacol Sci 21:369\u2013374","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6940_CR46","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1007\/s00520-019-04848-4","volume":"27","author":"CHLL Hong","year":"2019","unstructured":"Hong CHLL, Gueiros LA, Fulton JS et al (2019) Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27:3949\u20133967. https:\/\/doi.org\/10.1007\/s00520-019-04848-4","journal-title":"Support Care Cancer"},{"key":"6940_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00520-014-2378-x","volume":"23","author":"S Elad","year":"2015","unstructured":"Elad S, Raber-Durlacher JE, Brennan MT et al (2015) Basic oral care for hematology\u2013oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology (MASCC. Support Care Cancer 23:223\u2013236","journal-title":"Support Care Cancer"},{"key":"6940_CR48","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1002\/cncr.33100","volume":"126","author":"S Elad","year":"2020","unstructured":"Elad S, Cheng KKF, Lalla RV et al (2020) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126:4423\u20134431. https:\/\/doi.org\/10.1002\/cncr.33100","journal-title":"Cancer"},{"key":"6940_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2684924","volume":"2018","author":"O Di Fede","year":"2018","unstructured":"Di Fede O, Panzarella V, Mauceri R et al (2018) The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention. Biomed Res Int 2018:1\u201310. https:\/\/doi.org\/10.1155\/2018\/2684924","journal-title":"Biomed Res Int"},{"key":"6940_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jcpe.13290","volume":"47","author":"M Sanz","year":"2020","unstructured":"Sanz M, Herrera D, Kebschull M et al (2020) Treatment of stage I-III periodontitis\u2014the EFP S3 level clinical practice guideline. J Clin Periodontol 47:4\u201360. https:\/\/doi.org\/10.1111\/jcpe.13290","journal-title":"J Clin Periodontol"},{"key":"6940_CR51","first-page":"e1","volume":"38","author":"CM Cobb","year":"2017","unstructured":"Cobb CM, Daubert DM, Davis K et al (2017) Consensus conference findings on supragingival and subgingival air polishing. Compend Contin Educ Dent 38:e1\u2013e4","journal-title":"Compend Contin Educ Dent"},{"key":"6940_CR52","doi-asserted-by":"publisher","unstructured":"Ulvik IM, S\u00e6thre T, Bun\u00e6s DF, et al (2021) A 12-month randomized controlled trial evaluating erythritol air-polishing versus curette\/ultrasonic debridement of mandibular furcations in supportive periodontal therapy. BMC Oral Health 21:. https:\/\/doi.org\/10.1186\/s12903-021-01397-3","DOI":"10.1186\/s12903-021-01397-3"},{"key":"6940_CR53","doi-asserted-by":"publisher","unstructured":"Wilson WR, Gewitz M, Lockhart PB, et al (2021) Prevention of Viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation 143:. https:\/\/doi.org\/10.1161\/cir.0000000000000969","DOI":"10.1161\/cir.0000000000000969"},{"key":"6940_CR54","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/JPER.18-0157","volume":"89","author":"JG Caton","year":"2018","unstructured":"Caton JG, Armitage G, Berglundh T et al (2018) A new classification scheme for periodontal and peri-implant diseases and conditions \u2013 introduction and key changes from the 1999 classification. J Periodontol 89:S1\u2013S8","journal-title":"J Periodontol"},{"key":"6940_CR55","doi-asserted-by":"publisher","unstructured":"Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, Kornman KS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R, Tonetti MS (2018) Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 89 Suppl 1:S173\u2013S182.\u00a0https:\/\/doi.org\/10.1002\/JPER.17-0721","DOI":"10.1002\/JPER.17-0721"},{"key":"6940_CR56","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1002\/JPER.17-0719","volume":"89","author":"ILC Chapple","year":"2018","unstructured":"Chapple ILC, Mealey BL, Van Dyke TE et al (2018) Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 89:S74\u2013S84. https:\/\/doi.org\/10.1002\/JPER.17-0719","journal-title":"J Periodontol"},{"key":"6940_CR57","doi-asserted-by":"publisher","unstructured":"Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, Chen S, Cochran D, Derks J, Figuero E, H\u00e4mmerle CHF, Heitz-Mayfield LJA, Huynh-Ba G, Iacono V, Koo KT, Lambert F, McCauley L, Quirynen M, Renvert S, Salvi GE, Schwarz F, Tarnow D, Tomasi C, Wang HL, Zitzmann N (2018) Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol 89 Suppl 1:S313\u2013S318. https:\/\/doi.org\/10.1002\/JPER.17-0739","DOI":"10.1002\/JPER.17-0739"},{"key":"6940_CR58","doi-asserted-by":"publisher","first-page":"471035","DOI":"10.1155\/2014\/471035","volume":"2014","author":"L Rasmusson","year":"2014","unstructured":"Rasmusson L, Abtahi J (2014) Bisphosphonate associated osteonecrosis of the jaw: An update on pathophysiology, risk factors, and treatment. Int J Dent 2014:471035. https:\/\/doi.org\/10.1155\/2014\/471035","journal-title":"Int J Dent"},{"key":"6940_CR59","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jcms.2017.05.003","volume":"45","author":"G Topaloglu","year":"2017","unstructured":"Topaloglu G, Koseoglu OT, Karaca C, Kosemehmetoglu K (2017) The effect of chronic dental inflammation on development of stage 0 medication-related osteonecrosis of the jaw. J Cranio-Maxillofac Surg 45:1158\u20131164. https:\/\/doi.org\/10.1016\/j.jcms.2017.05.003","journal-title":"J Cranio-Maxillofac Surg"},{"key":"6940_CR60","doi-asserted-by":"publisher","unstructured":"Rao NJ, Wang JY, Yu RQ, et al (2017) Role of periapical diseases in medication-related osteonecrosis of the jaws. Biomed Res Int 2017:. https:\/\/doi.org\/10.1155\/2017\/1560175","DOI":"10.1155\/2017\/1560175"},{"key":"6940_CR61","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","volume":"18","author":"A Bedogni","year":"2012","unstructured":"Bedogni A, Fusco V, Agrillo A, Campisi G (2012) Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Oral Dis 18:621\u2013623. https:\/\/doi.org\/10.1111\/j.1601-0825.2012.01903.x","journal-title":"Oral Dis"},{"key":"6940_CR62","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/ORAL1040032","volume":"1","author":"R Mauceri","year":"2021","unstructured":"Mauceri R, Toro C, Panzarella V et al (2021) (2021) Oral squamous cell carcinoma mimicking medication-related osteonecrosis of the jaws (MRONJ): a case series. Oral 1:326\u2013331. https:\/\/doi.org\/10.3390\/ORAL1040032","journal-title":"Oral"},{"key":"6940_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.radonc.2020.12.026","volume":"156","author":"Y Zadik","year":"2021","unstructured":"Zadik Y, Ganor Y, Rimon O et al (2021) Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents. Radiother Oncol 156:275\u2013280. https:\/\/doi.org\/10.1016\/j.radonc.2020.12.026","journal-title":"Radiother Oncol"},{"key":"6940_CR64","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/odi.12049","volume":"19","author":"L Lo Russo","year":"2013","unstructured":"Lo Russo L, Lo Muzio L, Buccelli C et al (2013) Bisphosphonates-related osteonecrosis of the jaws: medicolegal issues. Oral Dis 19:425\u2013426. https:\/\/doi.org\/10.1111\/odi.12049","journal-title":"Oral Dis"},{"key":"6940_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/2045-9912.266997","volume":"9","author":"Y Suh","year":"2019","unstructured":"Suh Y, Patel S, Kaitlyn R et al (2019) Clinical utility of ozone therapy in dental and oral medicine. Med Gas Res 9:163\u2013167","journal-title":"Med Gas Res"},{"key":"6940_CR66","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.26355\/eurrev_202009_22855","volume":"24","author":"F Goker","year":"2020","unstructured":"Goker F, Donati G, Grecchi F et al (2020) Treatment of BRONJ with ozone\/oxygen therapy and debridement with piezoelectric surgery. Eur Rev Med Pharmacol Sci 24:9094\u20139103. https:\/\/doi.org\/10.26355\/eurrev_202009_22855","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6940_CR67","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jbo.2012.08.001","volume":"1","author":"CI Ripamonti","year":"2012","unstructured":"Ripamonti CI, Maniezzo M, Boldini S et al (2012) Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates-preliminary data Medical ozone gas insufflation in treating ONJ lesions. J Bone Oncol 1:81\u201387. https:\/\/doi.org\/10.1016\/j.jbo.2012.08.001","journal-title":"J Bone Oncol"},{"key":"6940_CR68","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1002\/hed.25944","volume":"41","author":"E Souza Tolentino","year":"2019","unstructured":"Souza Tolentino E, Castro TF, Michellon FC et al (2019) Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: systematic review. Head Neck 41:4209\u20134228. https:\/\/doi.org\/10.1002\/hed.25944","journal-title":"Head Neck"},{"key":"6940_CR69","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/pho.2010.2955","volume":"30","author":"P Vescovi","year":"2012","unstructured":"Vescovi P, Manfredi M, Merigo E et al (2012) Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg 30:5\u201313. https:\/\/doi.org\/10.1089\/pho.2010.2955","journal-title":"Photomed Laser Surg"},{"key":"6940_CR70","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1902\/jop.2017.170172","volume":"89","author":"L Chambrone","year":"2018","unstructured":"Chambrone L, Wang HL, Romanos GE (2018) Antimicrobial photodynamic therapy for the treatment of periodontitis and peri-implantitis: an American Academy of Periodontology best evidence review. J Periodontol 89:783\u2013803. https:\/\/doi.org\/10.1902\/jop.2017.170172","journal-title":"J Periodontol"},{"key":"6940_CR71","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00784-020-03584-y","volume":"25","author":"Z Lin","year":"2021","unstructured":"Lin Z, Strauss FJ, Lang NP et al (2021) Efficacy of laser monotherapy or non-surgical mechanical instrumentation in the management of untreated periodontitis patients. A systematic review and meta-analysis. Clin Oral Investig 25:375\u2013391","journal-title":"Clin Oral Investig"},{"key":"6940_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6267406","volume":"2016","author":"MC Minamisako","year":"2016","unstructured":"Minamisako MC, Ribeiro GH, Lisboa ML et al (2016) Medication-related osteonecrosis of jaws: a low-level laser therapy and antimicrobial photodynamic therapy case approach. Case Rep Dent 2016:1\u20134. https:\/\/doi.org\/10.1155\/2016\/6267406","journal-title":"Case Rep Dent"},{"key":"6940_CR73","doi-asserted-by":"publisher","first-page":"107690","DOI":"10.1155\/2014\/107690","volume":"2014","author":"P Vescovi","year":"2014","unstructured":"Vescovi P, Merigo E, Meleti M et al (2014) Conservative surgical management of stage i bisphosphonate-related osteonecrosis of the jaw. Int J Dent 2014:107690. https:\/\/doi.org\/10.1155\/2014\/107690","journal-title":"Int J Dent"},{"key":"6940_CR74","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/pho.2010.2835","volume":"29","author":"U Romeo","year":"2011","unstructured":"Romeo U, Galanakis A, Marias C et al (2011) Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg 29:447\u2013452. https:\/\/doi.org\/10.1089\/pho.2010.2835","journal-title":"Photomed Laser Surg"},{"key":"6940_CR75","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.3390\/ijerph18168432","volume":"18","author":"O Di Fede","year":"2021","unstructured":"Di Fede O, Canepa F, Panzarella V et al (2021) The treatment of medication-related osteonecrosis of the jaw (Mronj): a systematic review with a pooled analysis of only surgery versus combined protocols. Int J Environ Res Public Health 18:8432","journal-title":"Int J Environ Res Public Health"},{"key":"6940_CR76","unstructured":"Arduino PG, Broccoletti R, Carbone M, Carcieri P (2014) Testo atlante di patologia gengivale - Non placca correlata - Valutazioni cliniche e protocolli operativi. Publisher: Martina"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06940-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-06940-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06940-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T12:16:19Z","timestamp":1658405779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-06940-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["6940"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-06940-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding informati on has been added in the Funding Note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This expert opinion is based on a narrative review of the existing data and the clinical observations of an expert task force, which is composed of professionals experienced in the diagnosis and management of MRONJ. The expert opinion is informational in nature; the authors caution that the strategies described in this position paper might not be suitable for every, or any, purpose or application. Additionally, this expert opinion cannot substitute the individual judgment brought to each clinical situation by a patient\u2019s healthcare providers. As with all clinical materials, this position paper should be used with the clear understanding that continued research and practice could result in revision or updated recommendations.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}